Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells
Publisher: Spandidos Publications
ISSN: 1021-335X
Source: Oncology Reports, Vol.31, Iss.2, 2014-01, pp. : 983-988
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. :